Colorectal carcinoma: nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; a comparative study

<p>Abstract</p> <p>Background</p> <p>Colorectal carcinoma is a common and often fatal disease in which methods of early detection and monitoring are essential. The present study was conducted for measuring serum levels of nucleosomes, carcinoembryonic antigen (CEA) and...

Full description

Bibliographic Details
Main Authors: Mahgoub Samir S, Al-Shuneigat Jehad M, Huq Fazlul
Format: Article
Language:English
Published: BMC 2011-07-01
Series:Journal of Biomedical Science
Subjects:
Online Access:http://www.jbiomedsci.com/content/18/1/50
id doaj-9a12c304c965425188d4ec26b2857398
record_format Article
spelling doaj-9a12c304c965425188d4ec26b28573982020-11-25T00:42:13ZengBMCJournal of Biomedical Science1021-77701423-01272011-07-011815010.1186/1423-0127-18-50Colorectal carcinoma: nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; a comparative studyMahgoub Samir SAl-Shuneigat Jehad MHuq Fazlul<p>Abstract</p> <p>Background</p> <p>Colorectal carcinoma is a common and often fatal disease in which methods of early detection and monitoring are essential. The present study was conducted for measuring serum levels of nucleosomes, carcinoembryonic antigen (CEA) and CA 19-9 in patients newly diagnosed with colorectal carcinoma and confirmed by clinicopathological study.</p> <p>Method</p> <p>Thirty subjects were included in the current study: six normal subjects as a control group with mean age (45.6 ± 7.9) and twenty four colorectal carcinoma patients with mean age (46.9 ± 15.6), which were classified pathologically according to the degree of malignant cell differentiation into well differentiated (group I), moderately differentiated (group II) and poorly differentiated (group III). Fasting venous blood samples were collected preoperative.</p> <p>Results</p> <p>The results revealed a significant increase in serum level of nucleosomes in patients with poorly differentiated tumors versus patients with well differentiated tumors (p = 0.041). The levels of CEA and CA19-9 showed no significant increase (p = 0.569 and 0.450, respectively).</p> <p>Conclusion</p> <p>In conclusion, serum level of nucleosomes provides a highly sensitive and specific apoptotic marker for colorectal carcinoma.</p> http://www.jbiomedsci.com/content/18/1/50colorectal carcinomanucleosomescarcinoembryonic antigen (CEA) and CA 19-9tumor marker
collection DOAJ
language English
format Article
sources DOAJ
author Mahgoub Samir S
Al-Shuneigat Jehad M
Huq Fazlul
spellingShingle Mahgoub Samir S
Al-Shuneigat Jehad M
Huq Fazlul
Colorectal carcinoma: nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; a comparative study
Journal of Biomedical Science
colorectal carcinoma
nucleosomes
carcinoembryonic antigen (CEA) and CA 19-9
tumor marker
author_facet Mahgoub Samir S
Al-Shuneigat Jehad M
Huq Fazlul
author_sort Mahgoub Samir S
title Colorectal carcinoma: nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; a comparative study
title_short Colorectal carcinoma: nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; a comparative study
title_full Colorectal carcinoma: nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; a comparative study
title_fullStr Colorectal carcinoma: nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; a comparative study
title_full_unstemmed Colorectal carcinoma: nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; a comparative study
title_sort colorectal carcinoma: nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; a comparative study
publisher BMC
series Journal of Biomedical Science
issn 1021-7770
1423-0127
publishDate 2011-07-01
description <p>Abstract</p> <p>Background</p> <p>Colorectal carcinoma is a common and often fatal disease in which methods of early detection and monitoring are essential. The present study was conducted for measuring serum levels of nucleosomes, carcinoembryonic antigen (CEA) and CA 19-9 in patients newly diagnosed with colorectal carcinoma and confirmed by clinicopathological study.</p> <p>Method</p> <p>Thirty subjects were included in the current study: six normal subjects as a control group with mean age (45.6 ± 7.9) and twenty four colorectal carcinoma patients with mean age (46.9 ± 15.6), which were classified pathologically according to the degree of malignant cell differentiation into well differentiated (group I), moderately differentiated (group II) and poorly differentiated (group III). Fasting venous blood samples were collected preoperative.</p> <p>Results</p> <p>The results revealed a significant increase in serum level of nucleosomes in patients with poorly differentiated tumors versus patients with well differentiated tumors (p = 0.041). The levels of CEA and CA19-9 showed no significant increase (p = 0.569 and 0.450, respectively).</p> <p>Conclusion</p> <p>In conclusion, serum level of nucleosomes provides a highly sensitive and specific apoptotic marker for colorectal carcinoma.</p>
topic colorectal carcinoma
nucleosomes
carcinoembryonic antigen (CEA) and CA 19-9
tumor marker
url http://www.jbiomedsci.com/content/18/1/50
work_keys_str_mv AT mahgoubsamirs colorectalcarcinomanucleosomescarcinoembryonicantigenandca199asapoptoticmarkersacomparativestudy
AT alshuneigatjehadm colorectalcarcinomanucleosomescarcinoembryonicantigenandca199asapoptoticmarkersacomparativestudy
AT huqfazlul colorectalcarcinomanucleosomescarcinoembryonicantigenandca199asapoptoticmarkersacomparativestudy
_version_ 1725283102688804864